SCHEMBL30297993

SCHEMBL30297993

CCOC(=O)c1cn(CC2CCC2)c2nc(N3Cc4cccnc4C3)c(Cl)cc2c1=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ELANE P08246 1/20 0.39
▸ POLB P06746 3/20 0.38
▸ RXFP1 Q9HBX9 1/20 0.38
▸ ALDH1A1 P00352 5/20 0.38
▸ ATM Q13315 1/20 0.38
▸ TDP1 Q9NUW8 1/20 0.37
▸ HSD11B1 P28845 1/20 0.36
▸ LMNA P02545 3/20 0.36
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ HPGD P15428 2/20 0.35
▸ OPRK1 P41145 1/20 0.35
▸ P2RX3 P56373 1/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.34
▸ MAPT P10636 2/20 0.34
▸ TSHR P16473 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ HTT P42858 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30298089 0.89 PIK3CG (0.38) TDP1LMNAMEN1KMT2ATSHR
SCHEMBL30298037 0.81 CSF1R (0.39) ELANEPOLBRXFP1ALDH1A1HSD11B1
SCHEMBL30298030 0.81 CSF1R (0.38) ELANEALDH1A1HSD11B1LMNAKMT2A
SCHEMBL30954824 0.81 CSF1R (0.38) ELANEALDH1A1HSD11B1LMNAKMT2A
SCHEMBL31157482 0.80 FNTA (0.39) POLBALDH1A1TDP1MEN1KMT2A
Hydrochloric Acid SCHEMBL31157590 0.80 HRH1 (0.38) TDP1LMNAKDM4E
SCHEMBL30298040 0.80 TIPARP (0.37) —
SCHEMBL30298002 0.80 POLB (0.46) POLBRXFP1ALDH1A1ATMTDP1
SCHEMBL30298051 0.78 ELANE (0.35) ELANELMNAKMT2ATSHRKDM4E
SCHEMBL31157461 0.76 ELANE (0.37) ELANELMNAKMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240376100-A1 PAPD5 AND/OR PAPD7 INHIBITING 4-OXO-1, 4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID DERIVATIVES Redona Therapeutics, Inc. 2024-11-14 — — US disclosed
EP-4399206-A1 PAPD5 AND/OR PAPD7 INHIBITING 4-OXO-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID DERIVATIVES Redona Therapeutics, Inc. (US) 2024-07-17 — — EP disclosed
CN-118201914-A 4-Oxo-1, 4-dihydroquinoline-3-carboxylic acid derivatives as PAPD5 and/or PAPD7 inhibitors 雷多纳治疗公司 2024-06-14 — — CN disclosed
WO-2023039089-A1 PAPD5 AND/OR PAPD7 INHIBITING 4-OXO-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID DERIVATIVES TWENTYEIGHT-SEVEN, INC. (US) 2023-03-16 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240376100-A1 PAPD5 AND/OR PAPD7 INHIBITING 4-OXO-1, 4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID DERIVATIVES PAPSS1, OTUD7B, BRD7 ELANE 3603/4885POLB 2157/4885RXFP1 3348/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback